HCV infection in haemodialysed patients: A role for serum IL-10 and TGF-β1 in liver damage?

Digestive and Liver Disease

Volumn 40, Issue 10, 2008, Pages 827-833

  Burra, P ^a   Masier, A ^a   Morisco, F ^c   Di Leo, V ^a   Zorzi, M ^b   Senzolo, M ^a   Marchini, F ^a   Guido, M ^a   Canova, D ^a   Floreani, A ^a   Burroughs, A K ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Haemodialysis; HCV; IL 10; TGF 1

Indexed keywords

AMINOTRANSFERASE; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REFERENCE VALUE; SCORING SYSTEM; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMANS; INTERLEUKIN-10; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA1;

EID: 49149104520     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.01.022     Document Type: Article

References (43)

1. Alter M.J. Epidemiology of hepatitis C. Hepatology 26 (1997) S62-S65
2. Jadoul M., Poignet J.L., Geddes C., Locatelli F., Medin C., Krajewska M., et al. The changing epidemiology of hepatitis C (HCV) infection in haemodialysis: European Multicentre Study. Nephrol Dial Transpl 19 (2004) 904-909
3. Pol S., Vallet-Pichard A., Fontaine H., and Lebray P. HCV infection and hemodialysis. Sem Nephrol 22 (2002) 331-339
4. Natov S.N., Lau J.Y., Bouthot B.A., Murthy B.V., Ruthazer R., Schmid C.H., et al. Serologic and virologic profiles of hepatitis C infection in renal transplant candidates. New England Organ Bank Hepatitis C Study Group. Am J Kidney Dis 31 (1998) 920-927
5. Roth D. Hepatitis C virus: the nephrologist's view. Am J Kidney Dis 25 (1995) 3-16
6. Bergman S., Accortt N., Turner A., and Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis 45 (2005) 684-689
7. Herrine S.K., Michael B., Ma W.L., Rossi S., Dunn S.R., and Hyslop T. Development of an HCV infection risk stratification algorithm for patients on chronic hemodialysis. Am J Gastroenterol 97 (2002) 2619-2622
8. Espinosa M., Martin-Malo A., Alvarez de Lara M.A., Gonzales R., Rodriguez M., and Aljama P. Natural history of acute HCV infection in haemodialysed patients. Clin Nephrol 58 (2002) 143-214
9. Sterling R.K. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 94 (1999) 3576-3582
10. Caramelo C., Ortiz A., Aguilera B., Porres J.C., Navas S., Marriott E., et al. Liver disease pattern in haemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 22 (1993) 822-828
11. Stehman-Breen C.O., Emerson S., Gretch D., and Johnson R.J. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 32 (1998) 629-634
12. Espinosa M., Martin-Malo A., and Alvarez de Lara M.A. Risk of death and liver cirrhosis in anti-HCV positive long-term haemodialysis patients. Nephrol Dial Transpl 16 (2001) 1669-1674
13. Libetta C., Rampino T., and Dal Canton A. Polarization of T helper lymphocytes toward the Th2 phenotype in uremic patients. Am J Kidney Dis 38 (2001) 286-295
14. Rousseau Y., Haeffner-Caravaillon N., Poignet J.L., Meyrier A., and Carreno M.P. In vivo intracellular cytokine production by leucocytes during haemodialysis. Cytokines 12 (2000) 506-517
15. Cohen G., Haag-Weber M., and Horl W.H. Immune dysfunction in uremia. Kidney Int 62 (1997) S79-S82
16. Amoureux M.C., Rajapakse N., Hegyi E., Le D., Grandics P., and Szathmary S. Endotoxin removal from whole blood by a novel adsorption resin: efficiency and hemocompatibility. Int J Artif Organs 27 (2004) 480-487
17. Descamps-Latscha B., and Herbelin A. Long-term dialysis and cellular immunity: a critical survey. Kidney Int 43 (1993) S135-S142
18. Girndt M., Kaul H., Leitnaker C.K., Sester M., Sester U., and Köhler H. Selective sequestration of cytokine-producing monocytes during hemodialysis treatment. Am J Kidney Dis 37 (2001) 954-963
19. Girndt M., Sester M., Sester U., Kaul H., and Kohler H. Molecular aspects of T and B-cell function in uremia. Kidney Int 59 (2001) S206-S211
20. Mosmann T.R. Properties and function of interleukin-10. Adv Immunol 56 (1994) 1-26
21. Rennick D., Berg D., and Holland G. Interleukin 10: an overview. Prog Growth Factor Res 4 (1992) 207-227
22. Gressner A.M., Weiskirchen R., Breitkopf K., and Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci 7 (2002) 793-807
23. Bissel D.M., Roulot D., and George J. Transforming growth factor beta and the liver. Hepatology 34 (2001) 859-867
24. Pol S., Romeo R., Zins B., Driss F., Lebkiri B., Carnot F., et al. Hepatitis C virus RNA in anti-HCV positive hemodialysed patients: significance and therapeutic implications. Kidney Int 44 (1993) 1097-1100
25. Brady M.T., Mac Donald A.J., Rowan A.G., and Mills K.H. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 33 (2003) 3448-3457
26. Girndt M., Sester U., Sester M., Deman E., Ulrich C., Kaul H., et al. The interleukin-10 promoter genotype determines clinical immune function in haemodialysis patients. Kidney Int 60 (2001) 2385-2391
27. Wang S.C., Ohata M., Schrum L., Rippe R.A., and Tsukamoto H. Expression of IL-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem 273 (1998) 302-308
28. Tsukamoto H. Is interleukin10 antifibrogenic in chronic liver injury?. Hepatology 28 (1998) 1707-1709
29. Nelson D.R., Lauwers G.Y., Lau J.Y., and Davis G.L. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 118 (2000) 655-660
30. Fabrizi F., Lunghi G., Andrulli S., Pagliari B., Mangano S., Faranna P., et al. Influence of hepatitis C virus (HCV) viremia upon serum aminotransferase activity in chronic dialysis patients. Nephrol Dial Transpl 12 (1997) 1394-1398
31. Espinosa M., Martin-Malo A., Alvarez de Lara M.A., Soriano S., and Aljama P. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin Nephrol 54 (2000) 151-156
32. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
33. Commissione AISF. Il portatore di HCV con transaminasi normali; 2002.
34. Rampino T., Arbustini E., Gregorini M., Guallini P., Libetta C., Maggio M., et al. Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor. Kidney Int 56 (1999) 2286-2291
35. Girndt M., Kolher H., Schiedhelm-Weick E., Schlaak J.F., Meyer zum Büschenfeldeh K.H., and Fleischer B. Production of interleukin-6, tumor necrosis factorα and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 47 (1995) 559-565
36. Koziel M.J. Cytokines in viral hepatitis. Sem Liv Dis 19 (1999) 157-169
37. Brown P.M., and Neuman M.G. Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines. Clin Biochem 34 (2001) 167-171
38. Martín J., de Sequera P., Quiroga J.A., Rico M., Fernández M., Arocena C., et al. Role of haemodialysis and hepatitis C virus infection in spontaneous and induced cytokine production of patients with chronic renal disease. Cytokine 12 (2000) 1248-1252
39. Borazan A., Ustün H., Ustundag Y., Aydemir S., Bayraktaroglu T., Sert M., et al. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels. Mediat Inflamm 13 (2004) 201-204
40. Girndt M., Ulrich C., Kaul H., Sester U., and Sester M. Uremia-associated immune defect: the IL-10-CRP axis. Kidney Int 63 (2003) S76-S79
41. Balakrishnan V.S., Guo D., Rao M., Jaber B.L., Tighiouart H., Freeman R.L., et al. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65 (2004) 1449-1460
42. Boehmer E.D., Meehan M.J., Cutro B.T., and Kovacs E.J. Aging negatively skews macrophage TLR2- and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway. Mech Ageing Dev 126 (2005) 1305-1313
43. Uyemura K., Castle S.C., and Makinodan T. The frail elderly: role of dendritic cells in the susceptibility of infection. Mech Ageing Dev 123 (2002) 955-962